Dilated cardiomyopathy in turkeys: An animal model for the study of human heart failure

Laboratory Animal Science

Volumn 46, Issue 4, 1996, Pages 399-404

  Genao, Alvaro ^a   Seth, Kiernan ^a   Schmidt, Ulrich ^a   Carles, Maria ^a   Gwathmey, Judith K ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b Inst Cardiovasc Dis Muscle Res   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); ADENYLATE CYCLASE; BETA ADRENERGIC RECEPTOR; CALCIUM ION; FURAZOLIDONE; LACTATE DEHYDROGENASE; PROPRANOLOL; PYRUVATE KINASE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; ENZYME ACTIVITY; HEART DILATATION; HEART FAILURE; HEART FUNCTION; HEART MUSCLE CONTRACTILITY; NONHUMAN; PATHOPHYSIOLOGY; SARCOPLASMIC RETICULUM; TURKEY (BIRD);

ADENYLATE CYCLASE; ANIMALS; CALCIUM; CARDIOMYOPATHY, DILATED; DISEASE MODELS, ANIMAL; ELECTRIC STIMULATION; ENERGY METABOLISM; FURAZOLIDONE; HEART; HEART DISEASES; HUMANS; MICROFILAMENTS; MYOCARDIUM; POULTRY DISEASES; RECEPTORS, ADRENERGIC, BETA; SIGNAL TRANSDUCTION; TURKEYS;

EID: 0029814822     PISSN: 00236764     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Gwathmey, J. K., and A. J. Davidoff. 1993. Experimental aspects of cardiomyopathy. Curr. Opin. Cardiol. 8:480-495.
2. Hajjar, R. J., R. Liao, J. B. Young, et al. 1993. Pathophysiological and biochemical characterization of an avian model of dilated cardiomyopathy: comparison to findings in human dilated cardiomyopathy. Cardiovasc. Res. 27:2212-2221.
3. Chapados, R. A., E. J. Gruver, J. S. Ingwall, et al. 1992. Chronic administration of cardiovascular drugs: altered energetics and transmembrane signaling. Am. J. Physiol. 263: Heart Circ. Physiol. 32:H1576-H1586.
4. Graver, E. J., M. K. Glass, J. D. Marsh, et al. 1993. An animal model of dilated cardiomyopathy: characterization of dihydropyridine receptors and contractile performance. Am. J. Physiol. 265: Heart Circ. Physiol. 34:H1704-H1711.
5. 2+ channel antagonists in an animal model of dilated cardiomyopathy. Circ. Res. 73:1077-1089.
6. Gwathmey, J. K. 1991. Morphological changes associated with furazolidone-induced cardiomyopathy: effects of digoxin and propranolol. J. Comp. Pathol. 104:34-45.
7. Gwathmey, J. K., and R. J. Hajjar. 1992. Calcium-activated force in a turkey model of spontaneous dilated cardiomyopathy: adaptive changes in thin myofilament calcium regulation with resultant implications on contractile performance. J. Mol. Cell Cardiol. 24:1459-1470.
8. Michels, V. V., P. P. Moll, F. A. Miller, et al. 1992. The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy. N. Engl. J. Med. 326:77-82.
9. Krajinovic, M., B. Pinamonti, G. Sinagra, et al., and the Heart Muscle Disease Study Group. 1995. Linkage to familial cardiomyopathy to chromosome 9. Am. J. Hum. Genet. 57:846-852.
10. Fabiato, A. 1988. Computer programs for calculating total from specified free or free from specified total ionic concentrations in aqueous solutions containing multiple metals and ligands. Methods Enzymol. 157:378-417.
11. Salomon, Y. 1979. Adenylate cyclase assay, Adv. Cyclic Nucleotide Res. 10:35-55.
12. Gwathmey, J. K., and J. S. Ingwall. 1995. Basic pathophysiology of congested heart failure. Cardiol. Rev. 3:5, 282-291.
13. Ingwall, J. S., L. Nascimben, and J. K. Gwathmey. 1993. Heart failure: is the pathology due to calcium overload or to mismatch in energy supply and demand? p. 667-700. In J. K. Gwathmey, G. M. Briggs, and P. D. Allen (ed.), Heart failure: basic science and clinical aspects. Marcel Dekker, Inc., New York.
14. Ingwall, J. S., M. F. Kramer, M. A. Fifer, et al. 1985. The creatinine kinase system in normal and diseased myocardium. N. Engl. J. Med. 313:1050-1054.
15. Lowry, O. H., N. J. Rosenbrough, A. L. Farr, et al. 1951. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193:265-275.
16. Magwood, S. E., and D. F. Bray. 1962. Disease condition of turkey poults characterized by enlarged and rounded hearts. Can. J. Comp. Med. Vet. Sci. 26:268-272.
17. Gough, A. W., S. Pinn, T. J. Hulland, et al. 1981. Spontaneous cardiomyopathy: histopathologic and ultrastructural alterations of turkey heart tissue. Am. J. Vet. Res. 42:1290-1296.
18. Katz, A. M. 1992. Heart failure, p. 638-668. In Physiology of the heart. Raven Press, New York.
19. 2+ handling in myocardium from patients with end-stage heart failure. Circ. Res. 61:70-76.
20. Davidoff, A. J., and J. K. Gwathmey. 1994. Pathophysiology of cardiomyopathies. I. Animal models and humans. Curr. Opin. Cardiol. 9:357-368.
21. Gwathmey, J. K., and A. J. Davidoff. 1994. Pathophysiology of cardiomyopathies. II. Drug induced and other interventions. Curr. Opin. Cardiol. 9:369-378.
22. Schmidt, U., R. J. Hajjar, and J. K. Gwathmey. 1995. The force-interval relationship in human myocardium. J. Cardiac Failure 1:311-321.
23. Gwathmey, J. K., M. T. Slawsky, R. J. Hajjar, et al. 1990. Role of intracellular calcium handling in force-interval relationships of human ventricular myocardium. J. Clin. Invest. 85:1599-1628.
24. O'Brien, P. J., H. Shen, J. E. Weiler, et al. 1991. Myocardial calcium cycling defect in furazolidone cardiomyopathy. Can. J. Physiol. Pharmacol. 69:1833-1840.
25. Nascimben, L., P. Pauletto, A. C. Pessina, et al. 1991. Decreased energy reserve may cause pump failure in human dilated cardiomyopathy. Circulation 84(2):II-563.
26. O'Brien, P. J., C. R. Cory, and J. K. Gwathmey. 1993. Myocardial calcium cycling in human heart failure. Circulation 88(4):I-284.
27. 2+ and ATP-cycling imbalances in end-stage idiopathic dilated and ischemic cardiomyopathies. Cardiovasc. Res. 30:394-404.
28. Bristow, M. R., R. Ginsburg, W. Minobe, et al. 1982. Decreased catecholamine sensitivity and β-adrenergic-receptor density in failing human hearts. N. Engl. J. Med. 307:205-211.
29. Harrison, D. C. 1978. Effects of beta-blockade on circulatory dynamics. In E. Braunwald (ed.), Beta-adrenergic blockade: a new era in cardiovascular medicine: proceedings of an international symposium. Amsterdam: Excerpta Medica. 59-73.
30. Gaffney, T. E., and E. Braunwald. 1963. Importance of the adrenergic nervous system in the support of circulatory function in patients with congested heart failure. Am. J. Med. 34:320-324.
31. Jankus, E. F., G. R. Noren, and N. A. Staley. 1972 Furazolidone-induced cardiac dilatation in turkeys (research note). Avian Dis. 16:958-961.